“We should encourage [the development of] personalized medicine. It’s going to be specific to the target, it is going to cure more people, it will have less side effects.”
Diabetes type 1 is an autoimmune disease that can pose life-threatening risks when left untreated. Although less prevalent compared to diabetes type 2, the global incidence of type 1 diabetes is increasing at an alarming rate. Presently, approximately 9 million individuals worldwide grapple with this chronic ailment, including a significant number of children.
Commonly referred to as juvenile diabetes due to its frequent diagnosis during childhood, diabetes type 1 is not exclusive to any age group. Our body’s cells rely on insulin to effectively utilize sugar as an energy source. However, in the case of type 1 diabetes, the immune system mistakenly attacks the insulin-producing cells, depriving the body of this vital hormone.
Despite decades of research into this autoimmune condition, no definitive cure has been discovered thus far. The current approach entails symptom management through regular blood glucose monitoring and insulin injections.
Individuals with diabetes undergo approximately 65,000 injections and conduct over 80,000 blood glucose tests throughout their lifetimes. However, living with type 1 diabetes involves more than just daily insulin injections. It necessitates vigilant practices like carb counting, glucose monitoring, and mitigating hyperglycemic or hypoglycemic episodes. This commitment demands substantial dedication and significantly impacts both the patient’s daily life and that of their immediate circle.
Consider the following: What if we could address the root cause of this issue? What if, instead of relying solely on insulin injections, we could proactively prevent the destruction of the insulin-producing cells within the body?
This is where our innovative approach, Proteome Therapy, comes into play.
Given its intricacy, regulating the immune system presents considerable challenges. The immune system is a labyrinthine network of cells that necessitate precise communication for optimal function. When this communication falters or the cells deviate from their expected responses, the entire system falls into disarray.
Our groundbreaking Proteome Therapy is designed to restore this equilibrium in a non-intrusive and individualized manner. Acknowledging the uniqueness of each individual’s immune system, our therapy is tailored to the specific needs of the patient, recognizing that no two immune systems are alike. This individualized approach is pivotal to achieving successful outcomes.
At Alera Med, we’re committed to a holistic approach to precision medicine, recognizing the intricate web of interactions that sustain overall health.
Are you curious about the procedure? An advanced biomolecular test using a mere blood sample, enables the precise quantification of essential proteins. The exceptional sensitivity and specificity of this procedure provide insights into potential molecular irregularities underlying the patient’s condition.
Following bioinformatic and biostatistic analyses, we curate a comprehensive medical-scientific dossier. This report serves as the cornerstone for specialized recommendations. Expert clinicians utilize the insights gained to identify the specific deregulated key molecules that necessitate intervention through proteome therapy.
The journey continues as we craft nanobiological and serological strategies tailored to each patient’s unique profile. These cutting-edge approaches seek to restore equilibrium within the molecular landscape, aiming for personalized recovery.
Blood test to analyze the proteome profile
Production of tailored capsules and serum injections
Personalized medical treatment plan
Initial evaluation with our medical team
Rewrite your health story
Alera Med
A brand of Immunyo Limited
160 Collins Avenue East
Dublin 5, D05 E622
Dublin, Ireland
Speak to an expert
